×
Description of Baricinix 4
Baricinix is the first once-daily oral selective JAK1 and JAK2 inhibitor for the treatment of moderate to severe active rheumatoid arthritis (RA) who have not responded well enough to or could not tolerate at least one medicine called a tumor necrosis factor (TNF) antagonist.
Generic | Brand Name | Formulation & Strength | Pack Size |
---|---|---|---|
Baricitinib | Baricinix 4 | Tablet ( 4 mg ) | 30's Pot |
Website Prescribing Information Order Now
-
Fllow Us